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Background/aim: Dexmedetomidine (DEX) is an alpha-2 adrenergic agonist that is commonly used as a sedative and anesthetic. The
protective effects of DEX against oxidative damage under both in vitro and in vivo conditions have been demonstrated. It was aimed
to evaluate and compare the protective effects of DEX and vitamin C (Vit C) on DNA against H2O2-induced DNA damage in human
lymphocyte cell cultures in vitro by alkaline Comet assay.
Materials and methods: Lymphocyte cell cultures were divided into 5 groups, as the negative control, solvent control, positive control,
hydrogen peroxide (H2O2; 150 µM) + DEX (1 µM; 2.5 µM; 5 µM), and H2O2 (150 µM) + Vit C (1 µM; 2.5 µM; 5 µM), and incubated at
37 °C for 1 h. Cell viability was measured using the Trypan blue test. DNA damage was measured using the Alkali Comet Technique and
the % percent tail intensity was evaluated. Statistical analysis was performed using 1-way ANOVA and the Tukey multiple comparison
test.
Results: It was observed that H2O2 significantly induced DNA damage in the lymphocytes and this damage was decreased significantly
with Vit C and DEX. It was observed that Vit C at doses of 1 µM and 2.5 µM had a significantly stronger antioxidant effect, but there was
no significant difference between the antioxidant effects of Vit C and DEX with a dose of 5 µM. The dose of 5 µM DEX was found to be
the most effective in reducing oxidative DNA damage.
Conclusion: There is limited data on the protective effects of DEX against oxidative DNA damage. The primary effect might be
cytoprotection. The results herein showed that DEX was protective against H2O2-induced in vitro oxidative DNA damage in lymphocyte
cell cultures in a dose-dependent manner. DEX might have a potential therapeutic value in the prevention of oxidative DNA damage
in patients.
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1. Introduction
Dexmedetomidine (DEX) is a highly selective alpha-2
adrenergic receptor agonist that is commonly used in
clinical practice as a sedative and anesthetic agent due to its
sedative, analgesic, hemodynamic stabilizing, and diuretic
effects [1,2]. In addition to its sedative and anesthetic effects,
its antiinflammatory and antioxidant effects on vital organs,
such as the heart [3,4], lungs [5–7], kidneys [8], spinal
cord [9], and brain [10], have been demonstrated. DEX has
antiinflammatory and protective effects against oxidative
damage that have been shown under both in vitro and in
vivo conditions [11,12]. It shows these effects probably by
inhibiting the toll-like receptor (TLR) [4,13], suppressing
high-mobility group box 1 (HMGB1) factor [14], and
inhibiting the nuclear factor (NF)-κB and phosphoinositide-3
kinase (PI3K-) signaling pathway [3,15].

Oxidative stress, which is induced by ischemia,
mechanical stress, or toxins, is a condition that results from
an imbalance between the production of reactive oxygen
species (ROS) and free radicals, as well as inappropriate
antioxidant functions. The ROS-induced oxidative stress
in cells trigger a mechanism that, through the release
of cytochrome c and activation of caspase-3, leads to
intrinsic apoptosis. ROS play a critical role in maintaining
homeostasis and cell signaling [16]. Hydrogen peroxide
(H2O2), a reactive ROS derivative, is considered to be the
radical that is most responsible for oxidative damage. It
has been widely used to mimic in vitro oxidative stress in
many different cell types [17].
ROS can lead to DNA-strand breaks by loss of DNA
bases, known as apurinic/apyrimidinic sites, and inhibits
transcription. Moreover, the DNA strand break, an
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indicator of increased oxidative stress, is a complicated
process and it is more likely that the body will tend to
make mistakes when it attempts to repair itself [18].
There are many antioxidant and DNA repair systems that
protect the organism from undesirable consequences of
DNA damage. Although these systems work perfectly
throughout life, there may be conditions, such as disease
or aging, that lead to increased levels of DNA damage and
some external protection, such as vitamin administration,
would be needed [19]. Therefore, some medications, such
as DEX, which may also have some protective effects aside
from their crucial effects, are worth focusing on in terms
of patient health.
In the present study, the alkaline Comet assay was
used to detect DNA damage in lymphocytes. The alkaline
Comet assay, which detects single-strand breaks, as well
as alkali-labile sites, has been one of the most popular
techniques to detect DNA damage over the recent decades.
The Comet assay may be conducted in vitro using single
cells from immortalized cell lines or in vivo for any tissue
that can be dispersed into a single cell suspension. In the
Comet assay, the damaged DNA migrates away from the
undamaged DNA-containing nucleoid body, resembling
the structure of a Comet during electrophoresis. The
percentage of DNA in the tail is directly proportional to
the percentage of DNA damage and therefore, could be
measured [20]. In this study, it was aimed to evaluate the
antioxidant capability of DEX against H2O2-induced DNA
damage in human lymphocyte cell cultures in vitro by
alkaline Comet assay. Moreover, this effect was compared
with vitamin C (Vit C), which is one of the best-known
antioxidants against DNA damage.
2. Materials and methods
2.1. Chemicals
Vitamin C and DEX were obtained from Redox-C 100
mg/mL, (Bayer, Turkey) and Hipnodex 200 mcg/2 mL
(Haver Farma İlaç A.Ş., İstanbul, Turkey), respectively.
Other chemicals and reagents used in experiments were
commercially purchased from Sigma-Aldrich Corp. (St.
Louis, MO, USA).
2.2. Sample collection and lymphocyte isolation
This study was approved by the Ethics Committee of the
Ankara Health Training and Research Hospital of the
University of Health Sciences (Date: 01.08.2018, Approval
No.: 052). Peripheral blood from 3 healthy donors
(nonsmokers; 29, 33, and 49 years old) was collected
after all of the subjects signed an informed consent
form and filled out the questionnaire. The questionnaire
contained certain information about their demographic
characteristics and general health status. Subsequently,
lymphocytes were isolated using the density gradient
centrifugation technique [21].
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2.3. Viability test
Prior to initiating the experiments, exposure to H2O2, Vit
C, and DEX was assessed individually on the lymphocytes
in terms of cell viability. The final concentrations of the
treated lymphocytes were 50, 100, and 150 µΜ for H2O2,
and 1, 2.5, and 5 µΜ for Vit C and DEX. The compounds
were dissolved in 0.9% NaCl solution to prepare stock
solutions and their diluted solutions. The treated
lymphocytes were incubated for 1 h at 37 °C and then
the Trypan blue exclusion test was performed [22]. The
number of unstained/total cells was determined using a
hemocytometer under a light microscope.
2.4. Treatments
For determining the DNA damage, lymphocyte cultures
were performed in 5 groups comprising the negative
control (water), vehicle control (0.9% NaCl), positive
control (150 µΜ H2O2), as well as 1, 2.5, and 5 µΜ of DEX
or Vit C together with 150 µΜ of H2O2, for 1 h at 37 °C.
The final concentration of compounds in the medium
was adjusted to 1% v/v. Next, 3 independent experiments
with the samples from the 3 donors in duplicate were
performed. After the incubation process, the lymphocytes
were centrifuged for 3 min at 200 g and isolated.
2.5. Comet assay
For the detection of DNA damage, the alkaline version of
the Comet assay was performed, as described by Singh et
al. (1988), with minor modifications [23]. Briefly, 100 µL
of treated lymphocytes were mixed with 100 µL of 1% low
melting point agarose at 37 °C and was spread to a slide
pre-coated with 1% normal melting point agarose and
immediately covered with a coverslip. Duplicate slides
were made for each sample. After gel solidification, the
slides were immersed in lysis solution (2.5 M NaCl, 0.1
M Na2EDTA, 10 mM Tris HCl, pH 10, 1% Triton X-100)
and kept at 4 °C overnight. The slides were incubated
in a cold electrophoresis solution (0.3 M NaOH, 1 mM
EDTA, pH > 13) for 20 min to allow DNA unwinding.
Next, electrophoresis was performed at 4 °C, 25 V, and
300 mA for 20 min. After that, the slides were washed with
neutralization buffer (0.4 M Tris, pH of 7.5) and stained
with ethidium bromide (20 µg/mL). A total of 300 cells
were randomly selected per treatment and examined using
a fluorescence microscope (Zeiss Axioscope, Germany) at
400× magnification for image analysis (Comet assay III
image analysis system (Perceptive Instruments, UK). To
determine the DNA damage, the percent tail intensity
(also known as % tail DNA) was used.
2.6. Statistical analysis
Data on viability were displayed as a percentage of the
control that was not exposed to H2O2, Vit C, or DEX.
Values are the mean ± SEM of 3 independent experiments.
Statistical significance was determined by 1-way ANOVA
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followed by the the Tukey-Kramer multiple comparison
test using GraphPad Prism version 7 (demo version). P <
0.05 was considered statistically significant.
3. Results
3.1. Viability test
Figure 1 shows the effects of H2O2, Vit C, and DEX on the
lymphocyte viability. In the Trypan blue test performed to
determine whether the Vit C and DEX substances cause a
cytotoxic effect on the lymphocytes, viability was found to
be above 90% in all of the tested concentrations.
3.2. Detection of DNA damage
It was observed that H2O2 significantly induced DNA
damage in the lymphocytes and this damage decreased
significantly with Vit C and DEX. When H2O2 alone was
assessed in the 1-h treatments, the H2O2-induced DNA
damage exhibited a dose-dependent response (data not
shown). Thus, 150 µM H2O2, which was not cytotoxic but
induced significantly DNA damage, was adopted for the
main experiments.
The effect of DEX and Vit C in the lymphocytes cells
was demonstrated using various concentrations (1, 2.
5, and 5 µM). Lymphocytes incubated with H2O2 + Vit
C and H2O2 + DEX at different concentrations showed
significantly decreased DNA damage of up to 50% when
compared to H2O2 alone (P < 0.05) (Table). Although Vit
C and DEX caused an antigenotoxic effect on the DNA
damage, they were not dose-dependent. It was observed
that concentrations of 1 and 2.5 µM Vit C were more
effective than DEX at the same concentrations. On the
other hand, DEX showed a similar antigenotoxic effects
on the lymphocytes at a concentration of 5 µM when
compared to 5 µM Vit C (P = 0.946) (Figure 2).
4. Discussion
In general, oxidative DNA damage induces cytotoxicity,
leading to multiple organ damage, which may result in

multisystem organ failure. Oxidative DNA damage is
known to directly induce cytotoxicity and can also alter cell
signaling pathways. Interestingly, the source of oxidative
injury may be a key to the extent of cellular cytotoxicity
[24]. The overwhelming production of oxidative injury
threatens the integrity of protein oxidation and leads
to DNA strand breaks, resulting in tissue damage [25].
The aim of this study was to investigate the effects of the
alpha-2 adrenoceptor agonist, DEX, against H2O2-induced
oxidative DNA damage in vitro.
Mechanistically, it was previously reported that DEX
acts as an antiinflammatory agent and provides cell
protection by increasing the expression of cell survival
proteins and reducing apoptosis. In addition, DEX has a
structure similar to imidazoline and its antiapoptotic effect
is enhanced by the activation of imidazoline receptors
[26]. It has been demonstrated that TLR4 and NF-𝜅B
signaling is involved in the DEX-mediated protection
against oxidative injury. Gao et al. used TLR4 knockdown by TLR4-RNA transfection and overexpression by
TLR4-DNA transfection in vitro approaches to explore
the mechanisms underlying DEX-mediated protection
[4]. The expression of TLR4 has been shown to be
triggered through endogenous ligands, including damageassociated molecular patterns and cytokines. Terminal
deoxynucleotidyl
transferase-mediated
digoxigenin
deoxyuridine nick-end labeling, which is increased
oxidative damage staining to detect dead cells [5]. As a
result, DEX may have prevented the increased expression
of TLR4 by attenuating tissue injury and the pretreatment
with DEX resulted in almost complete attenuation of the
TLR4 expression associated with decreased cell death of
epithelial cells [4,5].
It has been suggested that human fetal osteoblast cells
pretreated with DEX could be protected against H2O2induced oxidative stress [27]. Cui et al. demonstrated that
DEX attenuated the bilirubin-induced injury of epithelial
alveolar cells, both in vitro and in vivo. In this condition,

Figure 1. Effects of the H2O2, Vit C, and DEX treatments for 1 h on the viability % of the
human lymphocytes.
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Table. Protective effects of Vit C and DEX on H2O2-induced
DNA damage on human lymphocytes. NC = Negative control;
VC = Vehicle control; *Compared to VC; #Compared to H2O2.
Treatments

Tail DNA %
(mean ± SEM)

P-value*

NC

1.75 ± 0.43

>0.9999

VC

1.38 ± 0.35

H2O2

37.55 ± 1.96

<0.0001

H2O2+Vit C 1 µM

16.12 ± 0.86

0.0003

<0.0001

H2O2+Vit C 2.5 µM

16.45 ± 1.92

0.0002

<0.0001

H2O2+Vit C 5 µM

16.46 ± 1.91

<0.0001

<0.0001

H2O2+DEX 1 µM

27.04 ± 3.75

<0.0001

0.0202

H2O2+DEX 2.5 µM

27. 2.45

<0.0001

0.0230

H2O2+DEX 5 µM

19.84 ± 2.53

<0.0001

<0.0001

P-value#

Figure 2. Vit C and DEX antigenotoxic effects on the lymphocytes
incubated with H2O2.

it was described as reducing the alveolar damage and
epithelial cell proliferation via its inhibitory effect on
bilirubin induced cell cycle arrest [7]. Moreover, it was
reported that astrocytes treated with DEX had significantly
increased neurotrophic factor production and were shown
to preserve cell viability via the release of neurotrophic
factors when compared to the control [9]. Although the
antiapoptotic and antiinflammatory effects of DEX have
been reported to be associated with phosphoinositide
kinase and extracellularly signal-regulated kinase signaling
pathways [4,5,9,12,28], there is limited data on its protective
effects against oxidative DNA damage. In the present study,
the antioxidant potential of DEX was investigated and
this effect was compared with Vit C in an in vitro model
by Comet assay. The results showed that DEX might be
a protective agent against H2O2-induced oxidative DNA
damage in lymphocyte cell cultures in vitro. Therefore
the primary effect of DEX might be cytoprotection. This
allows DEX to act as an antioxidant against oxidative DNA
damage following H2O2 administration. A concentration of
5 µM DEX was found to be the most effective in reducing
oxidative DNA damage. Although it began at higher doses,
this effect was comparable with that of Vit C.
The protective effect of DEX, which is comparative to a
highly effective antioxidant like Vit C, might be associated
either with phosphoinositide kinase and extracellularly
signal-regulated kinase signaling pathways or alteration in
transcription factor control. The mechanisms for altered
transcription factor control could either be via decreased
binding to promoter regions via oxidative damage to
DNA or more directly by redox regulation of transcription
factor activation [29] and/or altered DNA-binding due to
redox-induced modification of the transcription factor
protein [30].
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On the other hand, HMGB1, which is strong damageassociated molecular pattern released from dying cells
during oxidative damage, acts by binding to TLR-4 to
initiate the downstream NF-B signaling cascade that
greatly increases the synthesis of proinflammatory
cytokines [31]. HMGB1 proteins are targeted to particular
DNA sites in chromatin by either protein-protein
interactions or recognition of specific DNA structures.
Furthermore, the accumulation of HMGB1 protein is
found at sites of oxidative DNA damage in live cells, thus
defining HMGB1 as a component of an early DNA damage
response [14]. As shown in a previous study, DEX caused
reduced translocation of HMGB1 from the nucleus to the
cytoplasm. HMGB1 levels in the nucleus were significantly
reduced after oxidative damage, but the addition of DEX
significantly increased the HMGB1 protein levels in
the cytoplasm [14].
In conclusion, the results showed that in vitro oxidative
DNA damage in lymphocyte cell cultures can be prevented
by DEX administration. DEX showed protective effects
against H2O2-induced DNA damage in vitro and this
effect was comparable with that of Vit C, which is a known
antioxidant. It is therefore suggested that DEX might have
a potential therapeutic value in the prevention of oxidative
DNA damage in patients.
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